News, Publication, Updates

VasoGnosis Awarded Competitive Grant from the National Science Foundation

Milwaukee, August 25, 2020  Milwaukee startup VasoGnosis has been awarded a National Science Foundation (NSF) Phase I Small Business Technology Transfer (STTR) grant for $225,000 in collaboration with Medical College of Wisconsin to conduct research and development work on the development and validation of noninvasive high-fidelity serial aneurysm diagnostic software.

VasoGnosis is an AI-powered diagnostic and surgical planning software platform for cerebrovascular diseases. Neurosurgeons and interventional neuroradiologists are using VasoGnosis’ platform to make data-driven decisions.

Today, 150M+ people suffer from brain aneurysm globally. Each year, 500K people die and more are disabled from strokes or other cerebrovascular diseases, many of which are caused by the rupture of a brain aneurysm. VasoGnosis' mission is to save brains so people can continue to live healthy, independent lives. VasoGnosis’ AI-powered diagnostic and surgical planning software for neurovascular diseases helps neurosurgeons and interventional neuroradiologists make data-driven decisions before entering the operation room. VasoGnosis’ predictive analytics powered by big data helps doctors diagnose, monitor, and plan the surgical treatment of patients to improve outcomes and support for clinical decision-making.

“This grant from the NSF is critical for us as we work to commercialize our technology,” said VasoGnosis’s CEO Dr. Ali Bakhshinejad. “We are proud to represent Wisconsin’s growing startup community nationally.”

“We're grateful for the support of the National Science Foundation in our mission to translate the power of AI into better outcomes for patients suffering from neurovascular diseases" said Dr. Sundeep Mangla, Chief Medical Officer of VasoGnosis.

VasoGnosis was founded in 2019 based on Dr. Bakhshinejad’s research in patient-specific simulation for brain aneurysm surgery at the University of Wisconsin-Milwaukee under the supervision of Dr. Roshan D’Souza. VasoGnosis has benefited from the programs and support offered by gBETA Milwaukee, Health Wildcatters, and the University of Wisconsin-Milwaukee’s Lubar Entrepreneurship Center. 

“Dr. Bakhshinejad began with MCW as a postdoctoral fellow and his passion and drive toward connecting data and improved patient outcomes was immediately apparent,” said Kevin Koch, PhD, professor of Radiology at Medical College of Wisconsin. “MCW values the opportunity to develop partnerships and licensing agreements on this priority technology for neuroradiology. We hope to continue playing a crucial role on the pathway to provide clearance for this product.” 

“NSF is proud to support the technology of the future by thinking beyond incremental developments and funding the most creative, impactful ideas across all markets and areas of science and engineering,” said Andrea Belz, Division Director of the Division of Industrial Innovation and Partnerships at NSF. “With the support of our research funds, any deep technology startup or small business can guide basic science into meaningful solutions that address tremendous needs.”

NSF accepts Phase I proposals from small businesses twice annually, in June and December. Small businesses with innovative science and technology solutions and commercial potential are encouraged to apply. All proposals submitted to the NSF SBIR/STTR program undergo a rigorous merit-based review process. The NSF, the fifth largest distributor of SBIR awards among federal agencies, received more than 20,000 proposals over the decade-long period from 2008 to 2017, approving more than 3,600 (16.8 percent), according to an SSTI analysis of NSF data.

To learn more about America’s Seed Fund powered by NSF, visit:

About the National Science Foundation's Small Business Programs: America’s Seed Fund powered by NSF awards $200 million annually to startups and small businesses, transforming scientific discovery into products and services with commercial and societal impact. Startups working across almost all areas of science and technology can receive up to $1.75 million to support research and development (R&D), helping de-risk technology for commercial success. America’s Seed Fund is congressionally mandated through the Small Business Innovation Research (SBIR) program. The NSF is an independent federal agency with a budget of about $8.1 billion that supports fundamental research and education across all fields of science and engineering.

About VasoGnosis

VasoGnosis is a Milwaukee-based startup that has developed an AI-powered diagnostic and surgical planning software platform for cerebrovascular diseases. The company was founded in 2019 by Dr. Ali Bakhshinejad based on his research at University of Wisconsin-Milwaukee. To learn more about VasoGnosis, its team, and its technology, visit: